Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
N Engl J Med
.
2017 Mar 2;376(9):890-1.
doi: 10.1056/NEJMc1615712.
Authors
Eli Ipp
1
,
Pauline Genter
2
,
Kristin Childress
3
Affiliations
1
Harbor–UCLA Medical Center, Torrance, CA.
[email protected]
2
Los Angeles Biomedical Research Institute, Torrance, CA
3
Harbor–UCLA Medical Center, Torrance, CA
PMID:
28252263
DOI:
10.1056/NEJMc1615712
No abstract available
Publication types
Letter
Comment
MeSH terms
Cardiovascular Diseases
Diabetes Mellitus, Type 2*
Glycated Hemoglobin*
Humans
Substances
Glycated Hemoglobin A